Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas L Jennings

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 19, 2018
Increase in short-term of rejection in heart transplant patients receiving granulocyte colony-stimulating factorDouglas L Jennings
The Annals of Pharmacotherapy|December 20, 2014
The "doctors" will see you now: a pharmacist's take on the "Truth in Advertising" campaignDouglas L Jennings
Stroke|December 1, 2016
Letter by Jennings Regarding Article, "Stroke Risk and Mortality in Patients With Ventricular Assist Devices"Douglas L Jennings
The Annals of Pharmacotherapy|October 5, 2016
Heart Failure Therapy in 2016: SHIFTing the PARADIGM From Antiquated Therapies Toward Novel AgentsDouglas L Jennings
Circulation. Heart Failure|November 22, 2012
Letter by Jennings regarding article, "Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices"Douglas L Jennings
Journal of Pharmacy Practice|May 20, 2020
Use of Glycoprotein IIb/IIIa Inhibitors in the Modern Era of Acute Coronary Syndrome Management: A Survey of Cardiovascular Clinical PharmacistsCraig J Beavers, Douglas L Jennings
International Journal of Cardiology|February 28, 2017
Pre-cardiac transplant amiodarone use is not associated with postoperative mortality: An updated meta-analysisDouglas L Jennings, William L Baker
Pharmacotherapy|October 21, 2014
Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic managementDouglas L Jennings, Phillip A Weeks
The Annals of Pharmacotherapy|December 21, 2007
Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantationDouglas L Jennings, David J Taber
The Annals of Pharmacotherapy|April 17, 2016
Pre-Cardiac Transplant Amiodarone Use Increases Postoperative Mortality: A Meta-analysisWilliam L Baker, Douglas L Jennings
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 19, 2018
Increase in short-term of rejection in heart transplant patients receiving granulocyte colony-stimulating factorDouglas L Jennings
The Annals of Pharmacotherapy|December 20, 2014
The "doctors" will see you now: a pharmacist's take on the "Truth in Advertising" campaignDouglas L Jennings
Stroke|December 1, 2016
Letter by Jennings Regarding Article, "Stroke Risk and Mortality in Patients With Ventricular Assist Devices"Douglas L Jennings
The Annals of Pharmacotherapy|October 5, 2016
Heart Failure Therapy in 2016: SHIFTing the PARADIGM From Antiquated Therapies Toward Novel AgentsDouglas L Jennings
Circulation. Heart Failure|November 22, 2012
Letter by Jennings regarding article, "Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices"Douglas L Jennings
Journal of Pharmacy Practice|May 20, 2020
Use of Glycoprotein IIb/IIIa Inhibitors in the Modern Era of Acute Coronary Syndrome Management: A Survey of Cardiovascular Clinical PharmacistsCraig J Beavers, Douglas L Jennings
International Journal of Cardiology|February 28, 2017
Pre-cardiac transplant amiodarone use is not associated with postoperative mortality: An updated meta-analysisDouglas L Jennings, William L Baker
Pharmacotherapy|October 21, 2014
Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic managementDouglas L Jennings, Phillip A Weeks
The Annals of Pharmacotherapy|December 21, 2007
Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantationDouglas L Jennings, David J Taber
The Annals of Pharmacotherapy|April 17, 2016
Pre-Cardiac Transplant Amiodarone Use Increases Postoperative Mortality: A Meta-analysisWilliam L Baker, Douglas L Jennings
Pageof 10